Literature DB >> 8019787

Non-steroidal anti-inflammatory drugs: how do they damage the gut?

S Levi1, C Shaw-Smith.   

Abstract

NSAIDs are widely prescribed for the treatment of musculoskeletal disorders. The gastrointestinal tract, predominantly the stomach, bears the brunt of their side-effects. The basis of this toxicity is certainly multifactorial, with a wide range of local effects and mucosal defences being implicated. This review will highlight: (1) the epidemiology of NSAID-induced gastrointestinal toxicity; (2) their effects on prostaglandins, and the phenomenon of cytoprotection; (3) effects on neutrophil function; (4) effects on mucosal blood flow; (5) responses of the mucosa to damage (restitution, adaptation, and regenerative repair); (6) the relevance of growth factors; (7) interactions with Helicobacter pylori in ulcerogenesis, and finally (8) the effects of NSAIDs on the small intestine and colon.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019787     DOI: 10.1093/rheumatology/33.7.605

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  Epidemiology of perforated colonic diverticular disease.

Authors:  C R Morris; I M Harvey; W S L Stebbings; C T M Speakman; H J Kennedy; A R Hart
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

2.  Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database.

Authors:  François Clinard; Catherine Sgro; Marc Bardou; Patrick Hillon; Monique Dumas; Carmen Kreft-Jais; André Escousse; Claire Bonithon-Kopp
Journal:  Eur J Clin Pharmacol       Date:  2004-04-22       Impact factor: 2.953

3.  Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes.

Authors:  A Mahmood; A J FitzGerald; T Marchbank; E Ntatsaki; D Murray; S Ghosh; R J Playford
Journal:  Gut       Date:  2006-06-15       Impact factor: 23.059

Review 4.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 5.  Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.

Authors:  R La Corte; M Caselli; G Castellino; G Bajocchi; F Trotta
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

6.  Bovine colostrum is a health food supplement which prevents NSAID induced gut damage.

Authors:  R J Playford; D N Floyd; C E Macdonald; D P Calnan; R O Adenekan; W Johnson; R A Goodlad; T Marchbank
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

7.  Gastroprotective effects of oral nucleotide administration.

Authors:  A Belo; T Marchbank; A Fitzgerald; S Ghosh; R J Playford
Journal:  Gut       Date:  2005-08-09       Impact factor: 23.059

Review 8.  Misoprostol/NSAID fixed combinations. Help or hindrance in clinical practice?

Authors:  A Isdale; V Wright
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

9.  Reparative properties of a commercial fish protein hydrolysate preparation.

Authors:  A J Fitzgerald; P S Rai; T Marchbank; G W Taylor; S Ghosh; B W Ritz; R J Playford
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

10.  Human pancreatic secretory trypsin inhibitor stabilizes intestinal mucosa against noxious agents.

Authors:  Tania Marchbank; Asif Mahmood; Anthony J Fitzgerald; Jan Domin; Matt Butler; Robert A Goodlad; George Elia; Helen M Cox; David A van Heel; Subrata Ghosh; Raymond J Playford
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.